Voluntary ex ante transparency notice
Directive 2014/24/EU
Section I: Contracting
entity
I.1) Name and addresses
NWSSP Cardiff and Vale Local Health Board
Woodland House, Maes-Y coed Road
Cardiff
CF14 4HH
UK
Contact person: Nicola Arnold
E-mail: nicola.arnold@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://nwssp.nhs.wales/ourservices/procurement-services/
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Vagal Nerve Stimulator (VNS)
Reference number: CAV-DCO (22-23) 147
II.1.2) Main CPV code
33158210
II.1.3) Type of contract
Supplies
II.1.4) Short description
The Neurosciences department within Cardiff and Vale Local Health Board currently perform Vagal Nerve Stimulator (VNS) therapy. VNS therapy is delivered through an implanted device that sends mild pulses to the vagus nerve at regular intervals throughout the day in an effort to reduce and/or prevent seizures. Patients are referred to this type of therapy when drugs have failed to provide a more manageable treatment. These devices are programmable for a personalised therapy approach and the technology is highly specialised.
Currently Livanova hold the monopoly of the global market for VSN products as they hold the patent for the manufacture and production of these stimulators, therefore the Health Board are proposing to award a two year contract.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
600 000.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
33158210
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
University Hospital of Wales, Heath Park, Cardiff CF14 4XW
II.2.4) Description of the procurement
As stated in the description above.
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Negotiated procedure without prior publication
Justification for selected award procedure:
The works, supplies or services can be provided only by a particular economic operator for the following reason: absence of competition for technical reasons
Explanation:
Livanova hold the patent for VSN products and therefore have a monopoly of the global market. Due to this, the Health Board have no other option than to award a contract direct to Livanova UK Limited as these products are the only items that can reduce and/or prevent seizures for patients.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract/concession
Contract No: CAV-DCO (22-23) 147
V.2 Award of contract/concession
V.2.1) Date of conclusion of the contract/concession
14/02/2023
V.2.2) Information about tenders
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
LivaNova UK Ltd
1370 Montpellier Court, Gloucester Business Park
Gloucester
GL34AH
UK
NUTS: UKK1
The contractor is an SME:
No
V.2.4) Information on value of the concession and main financing terms (excluding VAT)
Total value of the concession/lot:
600 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
(WA Ref:128705)
VI.4) Procedures for review
VI.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Telephone: +44 2079477501
VI.5) Date of dispatch of this notice
14/02/2023